STOCK TITAN

Invesco Ltd. (EHC) discloses 4.9% Encompass Health ownership in 13G/A

(Moderate)
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Invesco Ltd. has reported a significant shareholding in Encompass Health Corp. As of 12/31/2025, Invesco, as a parent holding company to its investment advisers, may be deemed to beneficially own 4,972,725 shares of Encompass Health common stock, representing 4.9% of the class.

Invesco has sole voting power over 4,761,846 shares and sole dispositive power over 4,972,725 shares, with no shared voting or dispositive power. The shares are held of record by clients of Invesco’s advisers, and no single individual has more than 5% economic ownership.

Invesco certifies that the securities are held in the ordinary course of business and not for the purpose of changing or influencing control of Encompass Health, consistent with a passive investment reported on a Schedule 13G/A.

Positive

  • None.

Negative

  • None.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What percentage of Encompass Health (EHC) does Invesco Ltd. beneficially own?

Invesco Ltd. reports beneficial ownership of 4.9% of Encompass Health’s common stock. This stake is based on 4,972,725 shares held through clients of its investment advisers as of December 31, 2025, according to the Schedule 13G/A filing.

How many Encompass Health (EHC) shares does Invesco Ltd. control?

Invesco Ltd. may be deemed to beneficially own 4,972,725 Encompass Health shares. It has sole voting power over 4,761,846 shares and sole dispositive power over 4,972,725 shares, with no shared voting or dispositive authority disclosed in the filing.

Is Invesco’s Encompass Health (EHC) stake considered a passive investment?

Yes. Invesco certifies the Encompass Health securities were acquired and are held in the ordinary course of business, not to change or influence control. This language aligns with a passive ownership position reported on a Schedule 13G/A under SEC rules.

Who actually holds the Encompass Health (EHC) shares reported by Invesco Ltd.?

The filing states that the 4,972,725 shares of Encompass Health are held of record by clients of Invesco Ltd.’s investment advisers. Invesco reports them in its capacity as a parent holding company to these advisers, rather than as direct owner.

Does any single investor hold more than 5% economic ownership of Encompass Health via Invesco?

No. The Schedule 13G/A notes that no one individual has greater than 5% economic ownership. Shareholders of the relevant fund have rights to dividends and sale proceeds, but none exceeds the 5% economic ownership threshold for the Encompass Health class.

Which Invesco subsidiaries are associated with the Encompass Health (EHC) position?

The filing identifies several related entities: Invesco Advisers, Inc., Invesco Asset Management Limited, Invesco Investment Advisers LLC, Invesco Management S.A., and Invesco Capital Management LLC as subsidiaries connected with the reported holdings.





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G



Invesco Ltd.
Signature:Robert R. Leveille
Name/Title:Global Head of Compliance
Date:02/12/2026